Pfizer and BioNTech SE Submit Data on Covid Vaccine for Kids 5-11 to FDA; Emergency Use Authorization Could Come By Halloween The pharmaceutical companies are confident they're one step closer to making vaccination an option for millions of younger children.

By Kenny Herzog

Millions of anxious parents are one formality closer to having the option of vaccinating their kids against Covid-19. This morning, Pfizer and BioNTech SE announced that they have submitted data from comprehensive trial results of their mRNA vaccine on children ages 5-11 to the U.S. Food and Drug Administration (FDA). The statement referred to last week's disclosure that "the safety profile and immunogenicity data in children aged 5 to 11 years vaccinated at a lower dose are consistent with those we have observed with our vaccine in other older populations at a higher dose."

In other words, after a three-phase trial conducted with thousands of participants from diverse backgrounds, the companies are confident that a modified dosage of their product is safe and efficacious for kids in kindergarten and up.

An important note is that, although the FDA intends to immediately start poring over the data, Pfizer and BioNTech have not yet applied for Emergency Use Authorization from the agency, the final procedural step before vaccines can be administered those in question. But per their newest statement, that "is expected to follow in the coming weeks."

And as Dr. Anthony Fauci has mentioned in recent days, that could mean parents who choose to vaccinate their elementary-aged children might be able to do just that by late October.

As of this writing, nearly 687,000 Americans have died from Covid-19 infection. Between June 16 and August 14, child hospitalizations due to Covid infections rose nearly tenfold over the prior six-week period.

Related: Pfizer Says its COVID-19 Vaccine is Safe and Likely to Work In Younger Children, and it's Planning to Ask for Permission to Use it In Kids as Young as 5

Kenny Herzog

Entrepreneur Staff

Digital Content Director

Kenny Herzog is currently Digital Content Director at Entrepreneur Media. Previously, he has served as Editor in Chief or Managing Editor for several online and print publications, and contributed his byline to outlets including Rolling Stone, New York Magazine/Vulture, Esquire, The Ringer, Men's Health, TimeOut New York, A.V. Club, Men's Journal, Mic, Mel, Nylon and many more.

Editor's Pick

Related Topics

Business News

Costco Is Now Offering an Additional Exclusive Perk to Members in All 50 States

Members can now access discounted outpatient medical care through a partnership with healthcare startup Sesame.

Business News

Why This OnlyFans Star Is Walking Away from Making Millions a Month. 'Success Does Not Bring Self-Love.'

Malaysian model MSPUIYI has millions of followers, but she's quitting to pursue her dream.

Business News

8 People Hospitalized on JetBlue Flight Headed to Florida Due to Turbulence

The turbulent conditions occurred near Jamaica on a flight coming from Ecuador.

Business News

Dads Who Do This Simple Activity With Their Kids for 10 Minutes a Day Are More Likely to Raise High Achievers

The straightforward approach can give children an advantage over their peers.


Don't Be a Boring Brand – How to Create Brand Distinction That Has Everyone Turning Their Heads

In the minds of most consumers, you're selling commodities — unless you've created a brand distinction. This article will show you how to craft a brand that's not just known but unforgettable.

Business News

ChatGPT Will Soon Be Able to Speak, Listen and Have Instant Conversations

Open AI announced updates to the AI technology arriving in the next two weeks.